The company is preparing for the fourth quarter launch of its Aries sample-to-answer system and assays, as well as its NxTag Respiratory Pathogen Panel.
The microbial genetics analysis firm went public today offering 2.85 million units for $17.1 million in gross proceeds.
The growth in revenues was driven by a 177 percent increase in the firm's ConfirmMDx prostate cancer test.
The firm also said that it will restate its 2014 financial statements due to "errors related to the accounting for income taxes in our discontinued operations."
Premaitha launched its CE-marked in vitro diagnostic Iona test for noninvasive prenatal aneuploidy screening earlier this year.
Broken links are found throughout academic publications, and some services are trying to combat such link decay.
Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.
In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.
Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.